Discontinued — last reported Q4 '25

Non-Current Assets

Equity Method Investments

Ellington Financial Inc. Equity Method Investments decreased by 24.4% to -$39.48M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 24.4%, from -$31.73M to -$39.48M. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows a downward trend with a 92.8% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ4 2025Mar 2, 2026

How to read this metric

An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.

Detailed definition

These are investments in entities where the company exercises significant influence but does not have full control. The...

Peer comparison

Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.

Metric ID: equity_method_investments

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$0.00-$13.20M-$13.00M-$31.73M-$39.48M
QoQ Change+1.5%-144.1%-24.4%
YoY Change+1.5%-144.1%-24.4%
Range-$39.48M$0.00
Avg YoY Growth-55.7%
Median YoY Growth-24.4%
Current Streak2 quarters decline

Frequently Asked Questions

What is Ellington Financial Inc.'s equity method investments?
Ellington Financial Inc. (EFC) reported equity method investments of -$39.48M in Q4 2025.
How has Ellington Financial Inc.'s equity method investments changed year-over-year?
Ellington Financial Inc.'s equity method investments decreased by 24.4% year-over-year, from -$31.73M to -$39.48M.
What is the long-term trend for Ellington Financial Inc.'s equity method investments?
Over 5 years (2020 to 2025), Ellington Financial Inc.'s equity method investments has grown at a 92.8% compound annual growth rate (CAGR), from $1.48M to -$39.48M.
What does equity method investments mean?
The value of investments in other companies where the firm has significant influence but not total control.